2-(6-Phenylpyridazin-3-yl)-2,5-diazabicyclo[2.2.1]heptane

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 2-(6-Phenylpyridazin-3-yl)-2,5-diazabicyclo[2.2.1]heptane
• 化学式: C₁₅H₁₆N₄
• 分子量: 252.31
• InChiKey: UNNFMHIMJIHAMM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  41
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Substituted diazabicycloalkane derivatives
  申请人：Basha Anwer

  公开号：US20050101602A1

  公开（公告）日：2005-05-12

  Compounds of formula (I) Z-Ar 1 —Ar 2 (I) wherein Z is a diazabicyclic amine, Ar 1 is a 5- or 6-membered aromatic ring, and Ar 2 is selected from the group consisting of an unsubstituted or substituted 5- or 6-membered heteroaryl ring; unsubstituted or substituted bicyclic heteroaryl ring; 3,4-(methylenedioxy)phenyl; carbazolyl; tetrahydrocarbazolyl; naphthyl; and phenyl; wherein the phenyl is substituted with 0, 1, 2, or 3 substituents in the meta- or para-positions. The compounds are useful in treating conditions or disorders prevented by or ameliorated by α7 nAChR ligands. Also disclosed are pharmaceutical compositions comprising compounds of formula (I) and methods for using such compounds and compositions.

  式(I)的化合物 Z-Ar 1 —Ar 2 (I) 其中Z是一种二氮杂双环胺，Ar 1 是一个5-或6-成员芳香环，Ar 2 选自未取代或取代的5-或6-成员杂芳基环；未取代或取代的双环杂芳基环；3,4-(亚甲二氧基)苯基；咔唑基；四氢咔唑基；萘基；和苯基；其中苯基在间位或对位上取代有0、1、2或3个取代基。这些化合物在治疗由α7 nAChR配体预防或改善的病症或紊乱中有用。还公开了包含式(I)的化合物的药物组合物以及使用这些化合物和组合物的方法。
• [EN] BIARYL SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY MODULATORS<br/>[FR] DÉRIVÉS D'ALCANE AZABICYCLIQUE À SUBSTITUTION BIARYLE EN TANT QUE MODULATEURS DE L'ACTIVITÉ DU RÉCEPTEUR NICOTINIQUE DE L'ACÉTYLCHOLINE
  申请人：ABBOTT LAB

  公开号：WO2009067579A1

  公开（公告）日：2009-05-28

  The invention relates to biaryl substituted azabicyclic alkane derivatives, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.

  这项发明涉及取代的双芳基氮杂环戊烷衍生物，包括这种化合物的组合物，以及使用这种化合物和组合物治疗疾病和疾病的方法。
• FUSED BICYCLOHETEROCYCLE SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES
  申请人：Ji Jianguo

  公开号：US20080045539A1

  公开（公告）日：2008-02-21

  The invention relates to fused bicycloheterocycle substituted azabicyclic alkane derivatives, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.

  该发明涉及融合的双环杂环烃基取代的氮杂双环戊烷衍生物，包括此类化合物的组合物，以及使用这些化合物和组合物治疗病症和疾病的方法。
• SPIROCYCLIC AZAADAMANTANE DERIVATIVES AND METHODS OF USE
  申请人：Ji Jianguo

  公开号：US20080153860A1

  公开（公告）日：2008-06-26

  The invention relates to compounds that are spirocyclic azaadamantane derivatives derivatives, particularly spirocyclic azaadamantanyl ether or amine derivatives, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such compounds, and intermediates obtained during such processes.

  这项发明涉及螺环状氮杂金刚烷衍生物，特别是螺环状氮杂金刚烷基醚或胺衍生物，包括这些化合物的组合物，使用这些化合物和组合物的方法，制备这些化合物的过程，以及在这些过程中获得的中间体。
• Amino-aza-adamantane derivatives and methods of use
  申请人：Schrimpf R. Michael

  公开号：US20070072892A1

  公开（公告）日：2007-03-29

  The invention relates to amine-substituted aza-adamantane derivatives, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. Radiolabelled compounds useful for evaluating the binding affinity to α7 nicotinic acetylcholine receptors also are described.

  本发明涉及胺基取代的氮杂亚金刚烷衍生物，包含这些化合物的组合物，以及使用这些化合物和组合物治疗疾病和疾病的方法。还描述了用于评估与α7尼古丁酸乙酰胆碱受体结合亲和力的放射性标记化合物。